Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?

Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.

Want to read the full paper? Find it here. 

Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.